Puma Biotechnology
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $75,500 | $54,475 | $52,436 | $46,007 |
Gross Profit | 52,300 | 42,302 | 40,135 | 35,451 |
EBITDA | 26,555 | 13,454 | 10,765 | 8,240 |
EBIT | 18,200 | 10,732 | 8,002 | 5,444 |
Net Income | 13,400 | 8,844 | 5,855 | 2,974 |
Net Change In Cash | 75,500 | 54,475 | 52,436 | 46,007 |
Free Cash Flow | 14,455 | 9,663 | 14,062 | 3,551 |
Cash | 29,600 | 53,525 | 54,662 | 63,030 |
Basic Shares | 51,521 | 50,929 | 50,144 | 49,906 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $228,371 | $230,468 | $235,637 | $228,031 |
Gross Profit | 170,214 | 166,064 | 172,955 | 172,938 |
EBITDA | 53,342 | 48,076 | 47,523 | 21,889 |
EBIT | 42,404 | 36,552 | 36,004 | 12,049 |
Net Income | 31,111 | 30,278 | 21,591 | 2 |
Net Change In Cash | 228,371 | 230,468 | 235,637 | 228,031 |
Cost of Revenue | 3,500 | |||
Free Cash Flow | 41,731 | 38,862 | 14,369 | -22,827 |
Cash | 29,635 | 69,219 | 84,585 | 76,201 |
Basic Shares | 50,653 | 49,100 | 47,550 | 44,929 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0.29 |
2025-09-30 | $0.21 |
2025-06-30 | $0.12 |